Longitudinal Assessment of Global and Regional Left Ventricular Strain in Patients with Multisystem Inflammatory

Michael He1, David M Leone2, Richard Frye2

  • 1Department of Pediatrics, Yale School of Medicine, New Haven, CT, USA. Michael.He@yale.edu.

Pediatric Cardiology
|January 7, 2022
PubMed

Insights

Multisystem inflammatory syndrome in children (MIS-C) can cause heart issues. While global strain measures improve after COVID-19 recovery, some regional segments may show persistent impairment, indicating potential long-term risks.

Area of Science:

  • Pediatric Cardiology
  • Infectious Diseases
  • Cardiovascular Imaging

Background:

  • Multisystem inflammatory syndrome in children (MIS-C) is a serious complication of COVID-19.
  • Myocardial dysfunction is observed in acute MIS-C, but long-term subclinical injury data is limited.

Purpose of the Study:

  • To assess persistent subclinical myocardial injury in children after MIS-C using deformation imaging.
  • To investigate changes in left ventricular global longitudinal strain (GLS) and global circumferential strain (GCS) in the chronic phase.

Main Methods:

  • Retrospective review of 22 MIS-C patients.
  • Comparison of echocardiographic parameters including GLS, GCS, regional longitudinal strain (RLS), and regional circumferential strain (RCS) at acute, subacute, and chronic phases.
  • Analysis of changes over time (presentation, 14-42 days, and >42 days).

Main Results:

  • Mean GLS improved from -18.4% (acute) to -20.1% (chronic) (p=0.4).
  • Mean GCS improved from -19.4% (acute) to -23.5% (chronic) (p=0.03).
  • RLS and RCS showed recovery trends, except in the basal anterolateral segment, indicating persistent regional impairment.

Conclusions:

  • While global strain parameters normalize post-MIS-C, persistent regional strain abnormalities may exist.
  • These regional changes could serve as subclinical markers for future adverse cardiovascular events in pediatric patients post-MIS-C.

Related Concept Videos

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
103
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
40
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
43